4-1BB costimulator/anti-tumor associated antigen conditional bispecific antibody (ABL Bio)

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug Name4-1BB costimulator/anti-tumor associated antigen conditional bispecific antibody (ABL Bio)

Drug Alias Nametumor associated antigen-dependent 4-1BB agonist (ABL Bio)conditional 4-1BB agonist (ABL Bio)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 stimulants

TargetsTumor necrosis factor receptor superfamily member 9

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAbl Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesAbl Bio Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A